Abstract:The Receiver Operating Characteristic (ROC) curve is a crucial method for evaluating the effectiveness of diagnostic medical indicators and has found extensive applications. However, errors are inevitable in the data acquisition process. Therefore, discussions on error and various methods for improving and handling data have not only become the focus of academic discourse but also hold practical significance. Unlike general statistics, the diversity of error situations, ranges, and impacts in biostatistics often present unique challenges. In practical scenarios, such as drug experiments, limited sample sizes and variations in individual responses to the same drug necessitate the use of error models, data scales, and statistical processing based on historical data, biomedical knowledge, and experimental data. Furthermore, the choice of an appropriate method depends on the specific objectives of the experiment, which is essential for producing compelling conclusions. Importantly, the field of biology has introduced methods to address errors, such as cross-comparison experiments or repeated experiments, and data processing must adapt to changes in experimental designs. This paper presents a statistical approach based on the widely used practice of error reduction through repeated experiments in the context of assessing generic drug consistency. The paper first summarizes the common types of errors encountered in biostatistics and the corresponding analytical, control, and optimization measures. It explores several methods for calculating the Area Under the ROC Curve (AUC) when sampling error is introduced and applies error reduction through repeated experiments. Subsequently, the paper validates the methods under different error scenarios using simulated data, highlighting the suitability of different statistical models and their reasons for selection in cases where the difference between healthy and diseased populations is not substantial. This paper offers valuable insights into handling various types of real-world data to eliminate errors and obtain more accurate statistical conclusions.

Improving estimation of the volume under the ROC surface when data are missing not at random

Estimation of the volume under the receiver-operating characteristic surface adjusting for non-ignorable verification bias

Bayesian ROC surface estimation under verification bias

A Model for Adjusting for Nonignorable Verification Bias in Estimation of the ROC Curve and Its Area with Likelihood‐Based Approach

Efficient estimation of the volume under the ROC surface using auxiliary ranks information

Estimation of ROC Curve with Multiple Types of Missing Gold Standard

ROC Curve Estimation under Test-Result-dependent Sampling.

Nonparametric receiver operating characteristic curve analysis with an imperfect gold standard

Optimal two-phase sampling for comparing correlated areas under the ROC curves of two screening tests in the presence of verification bias

Smoothed Empirical Likelihood Inference for ROC Curve in the Presence of Missing Biomarker Values

Interval Estimation for the Difference in Paired Areas under the ROC Curves in the Absence of a Gold Standard Test

Robust and flexible inference for the covariate-specific ROC curve

Bayesian Bootstrap Inference for the ROC Surface

Semiparametric ROC surface estimation for continuous diagnostic tests via polytomous logistic regression procedures

Nonparametric Covariate Adjustment for Receiver Operating Characteristic Curves

A robust approach for ROC curves with covariates

Null Distribution of Volume Under Ordered Three-Class ROC Surface (VUS) With Continuous Measurements.

Comparison of methods for calculating confidence intervals of AUC in ROC curve considering sampling error

Joint Statistical Inference for the Area under the ROC Curve and Youden Index under a Density Ratio Model

Comparison the Correcting for Verification Bias in Studies of a Diagnostic Test

Nonparametric statistical inference method for partial areas under receiver operating characteristic curves, with application to genomic studies.